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Environmental risk assessment of chemicals depends on the production of toxicity data for
surrogate species of mammals, birds, and fish and on making comparisons between these and
estimated or predicted environmental concentrations of the chemicals. This paper gives an
overview of biomarker assays and strategies that might be used as alternatives, that is, to
replace, reduce, or refine currently used ecotoxicity tests that cause suffering to vertebrates. In
the present context a biomarker is a biologic response to an environmental chemical at the
individual level or below which demonstrates a departure from normal status. Of immediate
interest and relevance are nondestructive assays that provide a measure of toxic effect in
vertebrate species and that can be used in both laboratory and parallel field studies. A major
shortcoming of this approach is that such assays are currently only available for a limited number
of chemicals, primarily when the mode of action is known. Nondestructive assays can be
performed on blood, skin, excreta, and eggs of birds, fish, reptiles, and amphibians. An interesting
recent development is the use of vertebrate cell cultures, including transgenic cell lines that have
been developed specifically for toxicity testing. The ultimate concern in ecotoxicology is the
effects of chemicals at the level of populations and above. Current risk assessment practices do
not address this problem. The development of biomarker strategies could be part of a movement
toward more ecologic end points in the safety evaluation of chemicals, which would effect a
reduction in animal tests that cause suffering. Environ Health Perspect 106(Suppl 2):613-620
(1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/613-620walker/abstract.html
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Introduction
During the last 50 years great advances
have been made in the field ofanalytical
chemistry. The development and refine-
ment oftechniques such as gas chromatog-
raphy, mass spectroscopy, and atomic
absorption has facilitated the detection and
determination ofever smaller residues of
organic and inorganic pollutants in air,
water, soil, sediments, and biota. Thus
there has been a growing awareness ofthe
widespread contamination ofthe environ-
ment byawide variety ofchemicals because
ofthe activities ofhumans. Although the
levels ofchemicals have usually been very
low, reflecting the increasing sensitivity and
sophistication ofanalytical instruments, the
complexity ofpollution patterns has also
been evident. In response to political
pressures arising from mounting public
concern, a great deal ofanalytical work has
been done on environmental samples, and
there now exists a huge amount ofdata on
environmental levels oforganic and inor-
ganic chemicals. There is, however, one
fundamental problem: very little of this
data can be interpreted in biologic terms.
The harmful effects ofthese chemicals on
living organisms remain largelyunknown.
Central to the disciplines oftoxicology
and ecotoxicology is the concept ofdose
response. The interpretation of residue
data from the field depends on establishing
relationships between environmental
concentrations andharmful effects on living
This paper was prepared as background for the 13th Meeting of the Scientific Group on Methodologies for the
Safety Evaluation of Chemicals (SGOMSECI: Alternative Testing Methodologies held 26-31 January 1997 in
Ispra, Italy. Manuscript received at EHP9 May 1997; accepted 9 December 1997.
Address correspondence to Dr. C.H. Walker, 35 Victoria Road, Mortimer, Berks, RG7 3SH, England, United
Kingdom. Telephone: 0118 9 333761.
Abbreviations used: Ah receptor, aryl hydrocarbon receptor; B[a]P, benzo[alpyrene; CALUX, chemically acti-
vated luciferase gene expression; ELISA, enzymelinked immunosorbent assay; OP, organophosphorus; PAH,
polycyclic aromatic hydrocarbon; PCB, polychlorinated biphenyl; p,p'-DDE, p,p'-dichlorophenyl dichloroethylene;
T4, thyroxine; TBT, tributyl tin.
organisms, which is the principle on which
the biomarker approach is based (1-4).
This paper will review the application of
biomarker strategies in the field, noting the
difficulties in comparison ofdose-response
data from the laboratorywith dose-response
relationships measured in the field.
Destructive biomarker assays for vertebrates
will be mentioned onlyin passing. Emphasis
will be given to nondestructive assays for
vertebrates and to assays using invertebrates.
Concepts
TheBiomarkerConcept
In this paper a biomarker is defined as a
biologic response to an environmental
chemical at the individual level or below
which demonstrates a departure from nor-
mal status (5). The response may be at the
molecular, cellular, or whole-organism
level. Changes at the level ofpopulation,
community, or ecosystem are not included
in this definition, although they are the
ultimate concern ofecologists when apply-
ing the biomarker concept. The relation-
ship between biomarker responses of
individual organisms and consequent effects
at the levels ofpopulations and above will
be discussed later. The biomarker concept
is illustrated in Figure 1 (3). In Figure lA,
a relationship is shown between increasing
exposure to a chemical and the consequent
effects. Exposure in this case refers to the
internal concentration ofa chemical. It may
represent, for example, the increasing tissue
concentration with time when there is con-
tinuous exposure to a constant concentra-
tion ofa chemical in food, ambient water,
or air. The horizontal axis measures physio-
logic state and the vertical axis measures
health status. Where levels ofchemical are
sufficiently low, there is no disturbance of
homeostasis and the organism remains
healthy. As the concentration rises, how-
ever, the organisms become stressed and
must expend energy in defense mechanisms
(e.g., induction ofenzymes or metalloth-
ioneins) in an attempt to reduce the cellular
level ofchemical. Ifthe level of chemical
rises further, toxic damage occurs and the
organism will enter into a reversible dis-
eased state. At this stage stress proteins may
be released to repair cellular damage.
Finally, a further increase in concentration
will lead to an irreversible disease state and
the organismwill dieshortly thereafter.
In Figure iB, a number of biomarker
responses are shown that measure different

















Figure 1. Relationship between exposure to pollutant, health status, and biomarker responses. (A) Progression of
the health status of an individual as exposure to pollutant increases: h, the point at which departure from the nor-
mal homeostatic response range is initiated; c, the limit at which compensatory responses can prevent develop-
ment of overt disease; r, the limit beyond which the pathologic damage is irreversible by repair mechanisms. (B)
Response of five hypothetical biomarkers used to assess the health of the individual. Reproduced from Walker et
al. (7), with permission ofTaylor & Francis.
stages in the time-related intoxication
process. This is a conceptual diagram and
these are hypothetical biomarker responses.
The complete diagram does not arise from
an integrated experiment performed with a
single chemical on a particular organism.
However, it does represent the kind ofbio-
marker responses that occur and are there-
fore not unrealistic. Biomarker A shows a
similar relationship to parameters of toxic-
ity that have been well established for the
inhibition ofthe brain acetylcholinesterase
ofvertebrates by organophosphorus (OP)
pesticides (6). With birds, for example,
inhibition of up to 40% can be tolerated
without obvious symptoms of toxicity. In
the range of approximately 40 to 75%,
characteristic physiologic and behavioral
effects are seen. Above this range, extreme
symptoms of neurotoxicity occur, leading
quickly to death. The particular value of
this and other biomarker assays based on
the mechanism oftoxicitywill be explained
in "Desired Characteristics ofBiomarkers."
Biomarker B2 could represent the induc-
tion of an enzyme with a detoxifying
function that is not sustained when the
organisms enters the diseased state.
Biomarker B3 could represent the release
of stress proteins to repair cellular damage
caused by the chemical and biomarker B5
could represent cellular damage (e.g., lyso-
somal disruption) in the later stages of
intoxication. Thus, in principle, an appro-
priate suite ofbiomarker assays can moni-
tor the time-related sequence of changes
that underlie chemical toxicity, progressing
from an initial molecular interaction
through cellular disturbances to toxic man-
ifestations at the level ofthe whole organ-
ism. Given the appropriate technology it is
possible, in theory, to obtain an integrated
and in-depth picture of toxic changes




The value of biomarker assays that can
monitor the whole sequence of events
underlying toxicity has been mentioned.
Assays based on molecular mechanisms
of toxicity are particularly relevant here
because progressive molecular interactions
such as cholinesterase inhibitions can cause
a sequence ofbiochemical and physiologic
changes leading to toxic symptoms and
death. Other examples will be discussed
later. Such assays are relatively easy to con-
ceive and even to deliver when the molecu-
lar mechanisms of toxicity are known.
Unfortunately this knowledge is often lack-
ing. Pesticides represent something of an
exception to this rule. Insecticides, for
example, frequently have significant verte-
brate toxicity and information on mode of
action is often required by regulatory
authorities in connection with registration.
Other biomarker assays that monitor only
exposure are less informative when attempt-
ing to relate environmental levels ofchemi-
cals to toxicity. However, there are ecologic
considerations that are frequently over-
looked in medical toxicology. The opera-
tion ofdefense mechanisms (e.g., induction
ofenzymes, Figure 1), although not directly
related to toxicity, does involve energy
costs. In ecosystems the energy costs borne
in this way may have adverse effects on
reproduction or growth. Thus there may
be harmful effects at the level ofpopulation
that are a consequence ofthe operation of
defense mechanisms (7). In other words
certain biomarkers ofexposure for the indi-
vidual may be biomarkers of harmful
effects at the level ofpopulation.
Implicit in the present account is the
desirability ofdeveloping nondestructive
biomarkers for vertebrates (8). There are
both aesthetic and scientific reasons for this.
There is a strong commitment to wildlife
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conservation in the Western world, along
with growing opposition to the killing of
wild vertebrates (9). Also, nondestructive
sampling is generally preferable to destruc-
tive sampling, as it permits serial sampling
of individuals and minimizes the direct
influence ofthe experimenter on popula-
tions under investigation in the field.
At a practical and operational level there
are four desirable. characteristics ofthe bio-
marker assay: sensitivity, specificity, sim-
plicity, and stability. An assay should be
sensitlve enough to detect early stages ofthe
process of toxicity, before the organism
reaches the disease state (Figure 1). Such an
assay can give early warning ofthe harmful
effects of a pollutant on individuals.
Specificity is desirable because it can pro-
vide evidence ofthe harmful effect ofa par-
ticular type ofpollutant and thus evidence
ofcausality ifa link is established between
the level ofa pollutant and adverse effects at
the levels of individual and population.
Specificity is also limiting, restricting the
number ofchemicals to which a response
can be detected. Simplicity is desirable to
make an assay widely available to nonex-
perts in a cost-effective way. Diagnostic
kits such as the enzyme-linked immunosor-
bent assay (ELISA), which are widely avail-
able in medical pathology laboratories,
could be developed ifthere were sufficient
demand. Stability is important in the
sense that unstable and short-lived responses
are difficult to measure and interpret in
field studies.
In reality, no biomarker assay exists that
has all ofthese attributes, and it is unlikely
that any ever will. On the other hand this
limitation can be overcome by using com-
binations ofbiomarkers, a strategy that is in
any case to be recommended for other rea-
sons (see earlier discussions). Thus, asimple
and inexpensive biomarker may be widely
used to demonstrate a toxic effect in a pop-
ulation and a small number ofindividuals
from the sampled population may also be
assayed by a complex, expensive, specific
biomarker to provide evidence ofcausality
(i.e., attribution of effect to a particular
pollutant or group ofpollutants).
Biomarkers andInteracdveEfficts
A fundamental problem in the assessment
ofenvironmental effects ofpollutants is the
question of mixtures (7). Not uncom-
monly, organisms are exposed to complex
mixtures ofpollutants (e.g., polychlori-
nated biphenyls [PCBs], polycyclic aro-
matic hydrocarbons [PAHs], metals), albeit
at low concentrations. Toxicity testing is
nearly always restricted to individual
compounds; very little work being done on
combinations ofchemicals. Although sel-
dom used until now, certain biomarkers
provide a measure ofthe harmful effects of
mixtures in a nondestructive way (10,11).
In considering individual organisms, the
toxicity ofa mixture usually approximates
to the sum ofthe toxicities ofits individual
components. However, the major concern
in the present context is potentiation,
where toxicity is substantially greater than
the sum of individual toxicities. In this
case biomarkers that provide a measure of
toxicity should establish where there is
potentiation (e.g., because oftoxicokinetic
interactions). Biomarker responses not
dearly related to toxicity (e.g., induction of
certain detoxification enzymes) do not pro-
vide such a measure. The argument is dif-
ferent when considering effects at the level
ofpopulation and above. Biomarkers of
toxic effect as well as biomarkers that relate
to energy cost may provide evidence of
potentiation for reasons explained in "The
Biomarker Concept." However, it has not
yet been possible to establish links between
such biomarker responses and population
effects. In contrast, biomarkers of toxic
effect such as eggshell thinning due to pp-
dichloroethylene (p,p'-DDE) in birds and
imposex due to tributyl tin (TBT) in the
dogwhelk (Nucella lapillus) have been





concentrations (doses) ofpollutants and
biomarker responses can be established
under closely controlled conditions in the
laboratory. The important question is
whether the same or similar responses are
observed in the field. First, there are serious
practical difficulties in measuring dose and
response in the field, which will be
addressed in the next section. Second, the
field situation is likely to be complicated by
other factors that are not under the control
ofthe experimenter. The presence ofother
chemicals and other organisms and changes
in temperature, pH, wind speed, and rate
offlow ofwater may all have effects on a
dose-response relationship. Thus, knowl-
edge and/or control of environmental
factors are important when making com-
parisons between laboratory and field. The
use of mesocosms (e.g., artificial ponds,
simulated streams) may provide a halfway
point between the two extremes where
dose-response relationships may be tested
(12). Here, to a considerable extent, envi-
ronmental factors are under the control of
the experimenter. Also, knowledge of
potentially complicating environmental fac-
tors may lead to the design ofmore sophis-
ticated laboratory studies. Laboratory
studies may be designed to model real envi-
ronmental conditions more closely. For
example, other environmental chemicals
may be introduced into the test system to
discover whether potentiation occurs (as
discussed in "Biomarkers and Interactive
Effects"); temperatures and pH values may
be altered to see whether they affect the
dose-response relationship.
A major difflculty with laboratory and
field comparisons is that it is only possible
to study a tiny proportion ofthe species of
interest in the laboratory. Thus, the selec-
tion ofsensitive or key species that can be
studied in the laboratory is a critical consid-
eration. Species that are widely distributed
in polluted environments and are represen-
tative ofmajor groups ofanimals are logical
choices. Examples ofsuch species include
starling (Sturnus vulgaris), red-legged par-
tridge (Alectoris rufa cross), and pigeon
(Columba livia) as representatives ofbirds;
edible mussel (Mytilus edulis) as a represen-
tative ofmollusks; and crabs (Carcinusspp.)
as representatives of crustaceans (13-15).
Sometimes dose-response relationships for
biomarker assays that measure toxicity do
not vary greatly between species [e.g., brain
acetylcholinesterase inhibition in birds (6)].
A dose-response curve for one species may
be applicable to many other related species
in the field. Unfortunately this is often
not the case [e.g., relationship between
dichlorophenyl dichloromethylene (DDE)
and eggshell thinning in birds (1)].
A recent novel approach to the problem
under discussion is the use of in vitro bio-
marker responses to aid the process ofenvi-
ronmental risk assessment. A pertinent
example is the use ofa transfected cell line
that has a reporter gene e.g., the chemically
activated luciferase gene expression
(CALUX) system, which will be discussed
in "Use ofCell Cultures" (16). This kind
of system can be useful for providing an
integrated response ofa biochemical site of
action after exposure to a mixture of
related chemicals.
BiomarkerStrategies intheField
In environmental risk assessment, compar-
isons are made between measured or esti-
mated environmental concentrations and
estimated environmental toxicity (17).
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Both ofthese elements are extremelyhard to
determine with any degree ofaccuracy. The
objective ofthe biomarker approach, on the
other hand, is to give evidence ofenviron-
mental exposure and consequent toxic
effects. The extent to which an organism is
actually exposed to a known environmental
concentration comes into question. This is
relatively easy to address for aquatic organ-
isms when a pollutant is dissolved in water.
It is harder to determine for residues in sedi-
ments because their availability is often
uncertain. In the terrestrial environment, a
residue ofa pesticide on a seed may or may
not be taken up by a bird. Much depends
on the feeding behavior ofthe bird.
When investigating dose-response
relationships in the living environment,
there are, broadly speaking, two approaches:
the study of dose-response relationships
that already exist or causing the exposure of
organisms to pollutants by direct interven-
tion. In the first case, biomarker responses
can be estimated along pollution gradients
by making comparisons between polluted
organisms and clean organisms from similar
sites (controls). A major difficulty ofsuch an
approach is identifying sites that are truly
clean and representative ofpolluted areas.
The other approach can be more rigorously
controlled and involves manipulation of
either the organism or the chemical. One
strategy is to deploy clean organisms into
both polluted and control sites. Biomarker
assays may then be performed both before
and at different times after deployment
(18). Biomarker responses are then calcu-
lated by comparing results from assays for
polluted sites with those for the controlled
site and plotting a dose-response curve.
Another strategy is to deliberately release
the pollutant into the environment while
keeping a control area free of chemical.
Biomarker assays can then be performed
before and at different times after the release
of the chemical, and comparisons made
between samples from control and treated
areas to establish biomarker response. The
latter approach has been used in field trials
with pesticides e.g., the Boxworth experi-
ment (19,20). With these controlled studies
it is possible, in theory, to have properly
replicated experiments. However, this
depends on circumstances, and with rela-
tively extensive studies involving vertebrates
may not bepracticallypossible (20).
Biomarker Assays
In the following sections, some biomarker
assays that have already enjoyed application
or are at an advanced stage ofdevelopment
will be considered. Their attributes will be
reviewed in the light ofconcepts discussed
in the previous sections. Separate sections
will be devoted to molecular, cellular, and
whole-organism biomarkers.
MolecularBiomakerAssays
Vertebrates. ASSAYS USING BLOOD. It is
relatively easy to obtain blood samples
from most vertebrate animals, and there
are already an impressive number ofbio-
marker assays that can be performed on
blood (Table 1).
Both cholinesterases and carboxyl-
esterases are examples of'B' esterases that
occur in blood. OPs act as suicide sub-
strates, phosphorylating serine residues that
Table 1. Biomarker assays forblood.
Biomarker of
Biomarker Type ofenvironmental chemical toxic effect Characteristics Reference
Cholinesterase inhibition OPs, carbamate No Have been used as biomarkers ofexposure. (21-24)
Variability ofnormal levels a problem. Recent
immunochemical assays overcomethis problem
but are notavailable commercially.
Carboxylesterase inhibition OPs, carbamate No Same comments as above exceptthattheyhave (21,22,25)
not been widely used.
Increase in precursors ofblood Vitamin Kantagonists such aswarfarin Yes ELISA assays have been used in humans exposed to (26)
clotting protein (descarboxy and related rodenticides warfarin. Not known to what extentassayworks in
coagulation protein) otherspecies.
Fall in retinol (vitamin A) and Hydroxymetabolites ofcertain PCBs, Yes Have been used successfully on mammalian species (27,28)
thyroxine (T4) levels, and especially4-OH-3,3,'4,5'-TCB. including seals. Results with birdsvariable. Assayof
reduction ofavailable T4 T4 binding sites requires specialized laboratory.
binding sites oftransthyretin
Inhibition ofALAD Lead No Good specific testfor exposure to lead. Has been (1)
widely used and is readilyavailable.
Changes in porphyrin levels A numberofcompounds, including In some cases Notveryspecific. Some potential for use inthefield. (30)
halogenated compounds such as HCB,
3,3,'4,4'-TCB andTCDD
Formation of DNAadducts PAHs and otherenvironmental mutagens, Not at present Several techniques including 32Ppost-labelling. (29,31)
(white blood vessels) including oxyradicals state of HPLC/fluorescence and ELISA have been used in
knowledge environmental studies. Possibility ofdetection by
DNAfingerprinting.
DNA strand breaks PAHs and other environmental mutagens, Not at present Alkaline unwinding assayand Comet assay have (29)
including oxyradicals state of been used in environmental studies.
knowledge
Formation of hemoglobin PAHs and other environmental mutagens, No HPLC/fluorescence, GC/MS, and othercomplex (29)
adducts including oxyradicals analytical techniques.
Vitellogenin production in Estrogens Yes Determined by radioimmunoassay. Not specific (32)
male fish forparticularcontaminants.
Abbreviations: GC/MS, gas chromatography/mass spectroscopy; HCB, hexachlorobenzene; HPLC, high performance liquid chromatography; TCB, tetrachlorobiphenyl; TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin.
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exist at their active centers and so cause
virtually irreversible inhibition (21,22).
Depression ofblood 'B' esterase activities
can last for several days after exposure in
mammals and birds and considerably longer
in one species of lizard (23). Inhibition
provides a valuable biomarker ofexposure
to OPs and carbamates in field studies
(22), but does not give a reliable indication
of toxic effect (compare brain acetyl-
cholinesterase, which represents the site of
action ofthese compounds). A limitation of
these assays is thevariability ofesterase levels
in blood, making control values hard to
establish. Recent work concerns the devel-
opment ofELISA assays, which allow the
estimation ofspecific activity, thus avoiding
this problem and facilitating more sensitive
detection ofesterase inhibition (24,25).
Anticoagulant rodenticides such as
warfarin act as vitamin K antagonists,
thereby inhibiting the completion ofsyn-
thesis ofclotting proteins in the liver. The
precursors ofclotting proteins are released
into the blood instead ofthe fully synthe-
sized proteins. Over a period ofdays, the
levels ofclotting proteins in blood fall until
the blood will no longer clot and hemor-
rhaging occurs. ELISA assays exist for the
determination of a precursor of a clotting
protein in human blood (26). It is not yet
known whether the same assay is effective
in wild vertebrates ofinterest in ecotoxicol-
ogy. In principle, however, this could pro-
vide an excellent biomarker of toxic effect
for use in field studies. Currently, there is
concern about the possible effects of new
rodenticides related to warfarin (e.g., brod-
ifacoum and flocoumafen) on predators
and scavengers that feed on rodents (e.g.,
owls and corvids).
Another example ofblood biomarker
assays that measure toxic effects relates to
thyroxine (T4) antagonism of the PCB
metabolite 4'hydroxy-3,3'4,5'-tetrachloro-
biphenyl. This, and to a lesser extent other
PCB metabolites, can compete with T4
for binding sites on the blood protein trans-
thyretin. When T4 is displaced, trans-
thyretin dissociates from an associated
retinol-binding protein. Consequently both
T4 and retinol (vitamin A) are lost from
blood (27,28). A number of toxic effects
may result, including certain symptoms of
vitamin A deficiency. Three biomarker
assays have been used to monitor this toxic
interaction: reduction ofblood T4; reduc-
tion ofvitamin A; and reduction of the
number of free T4 binding sites on
transthyretin. These assays have been used
successfully in a number of mammalian
species, including seals. However, results
with birds have been variable; some species
apparently do not show the same mode of
action as mammals (28).
There has been considerable success in
developing assays for genotoxicity in med-
ical toxicology. PAHs, for example, form
adducts with the DNA ofwhite blood cells
(using techniques such as 32p postlabeling)
and also with hemoglobin ofred blood cells
(29). Assays have also been developed for
measuring DNA strand breaks (alkaline
unwinding assay and Comet assay). These
assays are being used in ecotoxicologic
studies, albeit usually on tissues such as liver
after destructive sampling. Although some
adducts can lead to mutation and conse-
quent toxic damage e.g., carcinogenesis,
there is not yet a clear relationship between
this biomarker assayand toxic effect.
Briefly, exposure to lead can be mea-
sured by aminolevulinic acid dehydratase
inhibition and changes in blood por-
phyrins (30) can be caused by a number of
chemical agents (Table 1).
SKIN AND OTHER TISSUES TAKEN BY
BIOPSY. Both residues ofpersistent chemi-
cals and cytochrome P450 have been mea-
sured in samples ofskin taken from animals.
Currently this approach is being followed in
astudyofdolphins from which skin samples
are taken by a dart (33). In principle it is
also possible to sample other tissues by
biopsy e.g., liver samples, to perform bio-
marker assays. The assays for genotoxicity
mentioned above may be performed on
such samples. Levels ofstress proteins can be
determined invarious tissues.
EGGS. Eggs ofbirds, amphibians, and
reptiles can be sampled to perform bio-
marker assays, a practice that is usually
regarded as nondestructive. Retinol (vitamin
A) levels in eggs can be affected by chlori-
nated organic compounds and PAHs (1).
ANALYSIS OF EXCRETA. Changes in
profiles ofexcretory products can be deter-
mined by various analytical procedures in
samples of feces and urine. Such changes
are relevant to the present discussion when
they are caused by the action of environ-
mental chemicals. A pertinent example is
the determination ofchanges in porphyrin
patterns in urine or feces by high perfor-
mance liquid chromatography following
exposure to chemicals (32). Nuclear
magnetic resonance spectroscopy has also
been used to detect changes in urinary
components (34,35).
Invertebrates. Molecular biomarker
assays in invertebrates have been imple-
mented to a limited extent. Much of the
early work with them has involved the
adaptation of biomarker assays (e.g.,
induction of cytochrome P450), which
are well established in vertebrates.
However, it has become rapidly apparent
how invertebrates can differ and verte-
brates (35), and there is clearly a need for
more fundamental work on the biochemi-
cal toxicology of invertebrates (aquatic
and terrestrial) if this field is to prosper.
Work of this kind has been conducted
with the edible mussel (M edulis). Studies
with digestive gland microsomes have
produced evidence ofinduction ofa form
ofcytochrome P450 by PAH (36).
Studies have also been done with
Carcinus spp. (15). Exposure to benzo[a]-
pyrene (B[a]P) caused an increase in the
B[a]P monoxygenase activity in micro-
somes from the hepatopancreas; this was
associated with an increase of a protein
band (48 kDa) resolved by sodium dodecyl
sulfate-polyacrylamide gel. Purification of
this protein has been carried out to deter-
mine ifit is a form ofcytochrome P450. A
major objective ofthis work is to obtain an
antibody to an individual form of P450
that can then be used in an immunochemi-
cal biomarker assay for Carcinus spp. and
other aquatic invertebrates.
There have also been reports of DNA
adduct formation byMytilusgalloprovincalis
when exposed to PAH (37).
Use of Cell Cultures. This is a
relatively new approach to the use ofbio-
marker strategies. An example ofparticular
interest and importance addresses the
problem ofthe combined effects of mix-
tures of organohalogen compounds that
cause aryl hydrocarbon (Ah) receptor-
mediated toxicity (16,38-40). One ofthe
most widely used destructive biomarker
assays is the induction ofhepatic microso-
mal cytochrome P450 lAI and associated
activity (ethoxyresorufin deethylase) caused
bycoplanar PCBs, polychlorinated dibenzo-
dioxins (dioxins), polychlorinated dibenzo-
furans, and certain PAHs. This induction
follows the interaction of the pollutants
with the so-called Ah receptor, and is one
of a number ofresponses associated with
the operation ofthe Ah receptor signaling
pathway. A number of toxic responses
(e.g., disturbances ofthyroid and sex hor-
mones, changes in levels ofvitamins A and
C) are also associated with the stimulation
of this pathway. Certain hepatoma cell
lines (e.g., mouse Hepa-lc lc 7' and rat H
4.IIe) contain the Ah receptor. Recently
such cells have been transfected with
reporter genes (16,40). One example is the
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CALUX system (16). Very small quantities
of organohalogen compounds added to
this system can cause the synthesis of
luciferase via an Ah receptor-dependent
pathway, and this leads to the emission of
photons. This system can give a measure
of the integrated effect of mixtures of
organohalogen compounds that interact
with the Ah receptor.
A number ofstudies have demonstrated
induction of P450s in fish hepatocytes,
including those ofrainbow trout (Salmo
Gairdneric) and flounder (Platychthisflesus)
(41-43). A recent example ofthis approach
involves the use of primary culture of
salmon (Salmo salar) hepatocytes exposed
to pollutants (44). Responses were mea-
sured by 35S-methionine/cysteine incorpo-
ration and Western blotting. There was
evidence for induction ofa stress protein by
four different pollutants: B[a]P, 2,3,3',4,4'-
pentachlorobiphenyl, AsO2-, and Cd. The
two organic pollutants induced cytochrome
P450 lAI in a dose-dependent manner.
Also, primary cultures oftrout hepatocytes
have been used to measure the activity of
environmental estrogens (32). The measured
response is an increase invitellogenin.
Certainly cell systems hold considerable
promise for the future and can provide bio-
marker assays based on the mode of toxic
action. Clearly, however, there are prob-
lems in extrapolating from responses such
as these to toxic effects on living organisms
exposed to the same levels ofchemicals.
Microorganisms. The Microtox test sys-
tem (Microbics Corp., Carlsbad, CA),
which employs the bioluminescent marine
bacterium Vibriofischeri, is commercially
available and widely used (45). Emission of
light bythe bacterium is regulated byaform
ofluciferase and toxicity is measured by the
degree ofinhibition oflight emission.
It should also be mentioned that bacte-
rial mutagenicity assays such as the Ames
test can be used to detect the presence of
mutagens in environmental samples,
including extracts oftissues and eggs.
Stmwtural Changes. Where samples of
tissues can be obtained, structural changes
caused by chemicals can be observed by
microscopy and electron microscopy,
including proliferation of endoplasmic
reticulum, lysosomal damage, mitochondrial
damage, hypertrophy, and hyperplasia.
Two ofthe most valuable biomarkers yet
discovered in the context ofecotoxicology
are based on structural change. When
organochlorine insecticides were widely
used, it was discovered that p,p'-DDE, a
persistent metabolite of the insecticide
p,p'-dichlorophenyltrichloroethane, could
cause eggshell thinning in certain species of
birds. This effect is caused by a reduction in
the transfer ofCa2+ in the shell gland, prob-
ably because ofinhibition ofCa2+ adeno-
sine triphosphatase. Species such as the
peregrine falcon (Falcoperegrinus), the spar-
rowhawk (Accipiter nisus), and the Gannet
(Sula bassana) all experienced eggshell thin-
ning due to environmental levels ofp,p'-
DDE. In some cases this caused a decline in
reproductive success, leading to population
decline (1). In another example, very low
levels ofTBT in coastal waters caused
imposex in female dogwhelks. The develop-
ment ofa penis caused blockage ofoviducts
and reproductive failure. Population decline
of the dogwhelk was widely reported in
Britain and other Western European mar-
itime countries as a result ofthis effect (7).
As in the earlier example, a physiologic bio-
marker response gave critical evidence,
causally linking the presence ofan environ-
mental chemical to population decline in a
dose-dependent fashion.
Tests of Cellular Function. In
M edulis, lysosomal damage caused by pol-
lutants has been studied using a physiologic
test (46). The action ofmitochondrial poi-
sons (e.g., uncouplers such as chlorinated
phenols, rotenone) can be established by
performing controlled studies on respiration
byisolated mitochondria.
Studies ontheWhole Organism
With vertebrates, harmful effects of
chemicals on the function of the whole
organism can be measured using physio-
logic and behavioral assays. Respiration,
cardiac function, blood flow, and neuroac-
tivity can be monitored using techniques
established bymedical scientists.
In the case of neurotoxic pollutants,
there is particular interest in behavioral
changes caused by sublethal effects on the
nervous system. It is worth emphasizing
that many poisons-including all four
major groups ofinsecticides-act as neuro-
toxins. OPs, for example, can cause changes
in the behavior ofvertebrates at levels of
exposure well below those that cause death
(6). In birds, movement, feeding behavior,
and singing have been affected. In the con-
text ofecology, disturbances offeeding or
reproduction can be more harmful to the
species than the straightforward lethal
toxicity ofchemicals.
In invertebrates, the effects ofchemicals
on thewhole organism have sometimes been
measured as changes in scope for growth.
This concept is based on an assessment of
the surplus energy that an organism has
for growth and reproduction after
accounting for the basic requirements for
respiration, tissue repair, and other func-
tions (47). Chemical stress will bring
an energy cost to an organism e.g., for
mounting defense systems or repairing tis-
sue damage caused by the chemical. The
larger this cost is, the less that can be
invested ingrowth orreproduction.
Recently other assays have been
developed for invertebrates. In Carcinus
spp., for instance, a cardiac monitor has
beendeveloped (15,48). Detailedanalysis of
this has produced evidence ofcharacteristic
responses to certain types ofmetalpollution.
Conclusions
In the foregoing account, biomarker
strategies were reviewed with the ultimate
objective ofusing them to obtain clear evi-
dence of toxic effects of environmental
chemicals on animals (especially at the level
ofpopulation and above) while minimizing
harm to vertebrates during the course ofthe
testing procedures. There is the immediate
problem that some ofthe mostvaluable bio-
marker assays currently used depend on
destructive sampling. Examples include
inhibition ofbrain acetylcholinesterase and
(unless available bybiopsy) the induction of
liver enzymes such as P450 lAI. Because of
the large differences that exist amongspecies
in their response to pollutants, extrapolation
ofdata from one species to another is no
easy matter. This problem is recognized in
environmental risk assessment where a large
safety factor is used in the estimation of
environmental toxicity from laboratory data
(17). Thus the use ofnondestructive bio-
marker assays in other species actually
exposed to pollutants in the field provides
the most dear cut and objective approach to
the problem. Using strategies described ear-
lier, harmful effects ofpollutants on individ-
uals can be measured in the field and
attributed to a particular chemical, or com-
bination ofchemicals, in a dose-dependent
manner. Data so obtained can then be used
to establish causal relationships between lev-
els ofpollutants and effects at the popula-
tion level. The effectiveness ofthis approach
has alreadybeen demonstrated in the case of
eggshell thinning caused byp,p'-DDE in
birds ofpreyand in imposexcaused byTBT
in thedogwhelk (1,7).
Although attractive in theory, such an
approach is limited by the relatively small
number ofavailable nondestructive assays.
Notwithstanding this general observation,
there is already a promising collection of
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assays that can be used in blood, which is
relatively easy to obtain from certain species
in the field. Although little used as yet,
there is considerable potential for the devel-
opment ofassays using excreta and tissues
taken bybiopsy. The eggs ofbirds, amphib-
ians, and reptiles are readily obtained and
could be much more widely used for
biomarker studies.
A very interesting, although largely
undeveloped, area is the use of in vitro
methods. The CALUX system, which can
measure the interaction ofcombinations of
chemicals with the Ah receptor, is a perti-
nent example (38,40). Cell cultures derived
from species being studied in the field can
be used. These may carry the sites for
action and certain ofthe detoxifying/activ-
ity enzymes relevant to particular types of
pollutant. However, the extrapolation of in
vitro data to in vivo is not a simple matter
even for the same species (9). In vitrometh-
ods may give valuable information on haz-
ards ofenvironmental chemicals to wild
vertebrates, but they cannot be expected to
give reliable predictions ofeffects on indi-
viduals, let alone populations, with our
present state ofknowledge.
Biomarker assays for invertebrates are
still in an undeveloped state. Whereas rapid
progress in medical toxicology has paved the
way for biomarker assays in other verte-
brates, invertebrates have proved very differ-
ent in critical aspects oftheir biochemistry
and physiology, making progress difficult
and slow. For example, antibodies raised to
mammalian forms ofcytochrome P450 did
not recognize P450s ofcertain invertebrates
(15). Also, the funding forwork on inverte-
brates has been very small in comparison to
the support given to biomarker studies in
medical toxicology. Biomarker studies on
invertebrates are ofparticular importance
when considering effects ofchemicals on
communities and ecosystems because of
their strong representation in lower trophic
levels. Their value in measuring or predict-
ing effects ofchemicals on invertebrates is,
however, limited. Because they are so differ-
ent biochemically, they cannot be regarded
as simple surrogates for vertebrates when
considering biomarker responses related to
toxic effect. They can, however, provide
useful indications ofexposure ofvertebrates
to pollutants in the natural environment. In
aquatic ecosystems they can give indications
ofavailable pollutants in the water column.
They also give some indication of the
residue burden that will be passed on to
vertebrates that preyon them.
In conclusion, nondestructive bio-
marker assays on vertebrates that make
appropriate comparisons between labora-
tory and field provide a logical approach
to the assessment of the environmental
effects of pollutants, which has already
proved its worth. Such assays are ofmost
value when they can be used across a
range ofspecies. Specificity for a particu-
lar type ofchemical is desirable; for a par-
ticular species it is too limiting. In vitro
assays with vertebrate material hold great
promise, but are at an early stage ofdevel-
opment and will always raise the problem
ofextrapolation to in vivo. Finally, inver-
tebrate biomarker assays are of funda-
mental interest in regard to assessment of
pollutant effects at the levels of commu-
nity and ecosystem. They are potentially
valuable for giving measures of exposure
ofvertebrates to pollutants in the natural
environment. The development of bio-
markers for invertebrates and in vitro
biomarkers for vertebrates is at an early
stage. Biomarkers have the potential to
greatly advance our knowledge of the
environmental effects of chemicals on
animals. However, this would require
considerable investment as part of a
long-term strategy.
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